期刊文献+

多药耐药基因1C3435T基因多态性对胃溃疡患者抗幽门螺杆菌治疗的影响 被引量:8

Influence of multidrug resistance gene 1 C3435T genetic polymorphism on the eradication of gastric ulcer with Helicobacter pylori infection
原文传递
导出
摘要 目的探讨多药耐药基因(MDR)IC3435T基因多态性对胃溃疡患者抗幽门螺杆菌(rio)治疗的影响。方法共采集Hp阳性的胃溃疡患者106例,按抽签法随机分成EAC组(埃索美拉唑20meg次、克拉霉素0.5eg次、阿莫西林1.0g/次,均2次,d)和0AC组(奥美拉唑20mg/g次、克拉霉素0.5g,次、阿莫西林1.0g/次,均2次/a),每组53例,进行为期1周的抗Hp治疗,治疗结束至少4周检测Hp;采用聚合酶链反应.限制性内切酶技术检测两组MDR1基因多态性,记录并分析MDR1C3435T基因多态性对抗Hp治疗的影响。结果EAC组Hp根除率为84.9%(45/53),与OAC组的77.4%(41/53)比较差异无统计学意义(P〉0.05),两组MDR1C3435T不同基因型间Hp根除率比较差异亦无统计学意义(P〉0.05)。携带TT型基因Hp根除率为66.7%(16/24),携带CT型基因为86.3%(44/51),携带CC型基因为83.9%(26,31),携带,TT型基因Hp根除率最低,差异有统计学意义(P〈0.05)。两组携带TT型基因患者Hp根除率均低于其他两种基因型,差异有统计学意义(P〈0.05)。结论MDR1C3435T基因多态性与胃溃疡患者Hp根除疗效有关,携带TT型基因患者Hp根除率低。 Objective To study the influence of multidrug resistance gene (MDR)I C3435T genetic polymorphism on the eradication of gastric ulcer with Helicobacter pylori (Hp) infection. Methods A total of 106 gastric ulcer patients with positive Hp were randomly divided into two groups by lot with 53 cases each. One group was assigned with 20 mg esomeprazole, 0.5 g clarithromycin, 1.0 g amoxicillin twice one day(EAC group), and the other group was assigned with 20 mg omerprazole, 0.5 g clarithromycin, 1.0 g amoxiciUin twice one day (OAC group ). The therapy of two groups was one week. Hp was detected at least 4 weeks after the end of treatment. MDR1 C3435T genetic polymorphism was determined by polymerase chain reaction-restriction fragment length polymorphism assay. The influence of MDR1 C3435T genetic polymorphism on the eradication of Hp was recorded and analyzed. Results The Hp eradication rate was 84.9%(45/53) and 77.4%(41/53) in EAC group and OAC group,and there was no significant differencebetween two groups (P〉 0.05 ). There was no significant difference in the Hp eradication rate in patients with different MDR1 C3435T genotypes in two groups (P 〉 0.05 ). The Hp eradication rate was 66.7%(16/24), 86.3%(44/51 ), 83.9%(26/31 ) in TT, CT, CC genotype, and there was significant difference(P〈 0.05). The Hp eradication rate in patients with Tr genotype was lower than that in patients with CT,CC genotype, and there was significant difference (P〈 0.05). Conclusion There is significant relationship between the effect of gastric ulcer with Hp eradication and MDRI C3435T genetic polymorphism, and the Hp eradication rates of patients with Tr genotype are more lower.
出处 《中国医师进修杂志》 2013年第19期4-6,共3页 Chinese Journal of Postgraduates of Medicine
基金 基金项目:深圳市科技计划(200602026)
关键词 P糖蛋白 基因型 胃溃疡 螺杆菌 幽门 奥美拉唑 P-glycoprotein Genotype Stomach ulcer Helicobacter pylori Omeprazole
  • 相关文献

参考文献2

二级参考文献13

  • 1焦正,梁惠琪,丁俊杰,李中东,施孝金,钟明康.MDR1基因多态性对口服环孢素A药代动力学的影响[J].药学学报,2004,39(12):971-974. 被引量:10
  • 2WANG Wei,ZHANG Xiao-dong,GUAN De-lin,LUE Yue-ping,MA Lin-lin,HU Xiao-peng,ZHANG Peng,WANG Yong,CHEN Xiao.Relationship between MDR1 polymorphism and blood concentration of cyclosporine A[J].Chinese Medical Journal,2005(24):2097-2100. 被引量:2
  • 3Intemafiongal Agency for Research on Cancer, World Health Orga- nization. Infection with Helicobacter pylori. In Schistosomes, liver flukes and Helicobacter pylori. IARC Lyon, 1994:177-202. 被引量:1
  • 4Fock KM, Katelaris P, Sugano K, et al. Second Asia-Pacific Con- sensusGuidelinesforHelicobacterpyloriinfe~tion. J Gastronterol Hepatol, 2009,24:1587-6000. 被引量:1
  • 5Hoffmeyer S, Burk O, yon Richter O, et al. Functional polymor- phisms of the human multidrug resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expres- sion and activity in vivo. Proc Natl Acad Sci USA, 2000,97:3473-3478. 被引量:1
  • 6Pauli-Magnus Ch, Rekcrsbrink S, Klotz U, et al. Interaction of omeprazole and pantoprazole with P -glycoprotein. Naunyn Schmiedebergs Arch Pharmacol, 2001,364:551-557. 被引量:1
  • 7Gawrofiska-Szklarz B, Wrzesniewska J, Starzyfiska T, et al. Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection. Eur J Clin Pharmacol, 2005,61:375-379. 被引量:1
  • 8Sakacda T, Nakamura T, Okumura K. MDRI genotype-rclated phar- macokinefics and pharmacodynamics. Biol Pharrn Bull, 2002,25: 1391-1400. 被引量:1
  • 9Arceci RJ. Clinical significance of P-glycoprotein in multidrug re- sistance malignancies. Blood, 1993,81:2215-2222. 被引量:1
  • 10Chowbay B, Cumaraswamy S, Cheung YB, et al. Genetic polymor-phisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypcs on cycolsporin disposition in heart transplant re- cipients. Pharmacogenetics, 2003,13:89-95. 被引量:1

共引文献12

同被引文献48

引证文献8

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部